Nation

Johnson and Johnson’s single-dose Covid-19 vaccine given approval for EUA in India

This will be India's fifth Covid-19 vaccine to get approval after Covishield, Covaxin, Sputnik V, and Moderna in India.

By Rajan Nath -- August 07, 2021 1:52 pm -- Updated:August 07, 2021 2:00 pm

The US pharma giant Johnson and Johnson's single-dose Covid-19 vaccine has become the fifth vaccine to be approved by the government of India.

Taking to Twitter, the Union Health Minister Mansuk Mandaviya informed the same.

Also Read | Tokyo Olympics: Indian men’s hockey team clinch bronze, win medal after 41 years

Vials and syringes of the Johnson and Johnson Janssen Covid-19 vaccine are displayed. (AFP)

"India expands its vaccine basket! Johnson and Johnson’s single-dose COVID-19 vaccine is given approval for Emergency Use in India. Now India has 5 EUA vaccines," he tweeted.

Also Read | Tokyo Olympics 2020: Wrestler Ravi Dahiya takes silver after losing final to ROC’s Zavur Uguev

Johnson & Johnson COVID-19 vaccine likely to be available in India by July - price and other details here

This will be India's fifth Covid-19 vaccine to get approval after Covishield, Covaxin, Sputnik V, and Moderna in India.

Earlier on August 5, 2021, the Johnson and Johnson Pvt. Ltd had applied for Emergency Use Authorization (EUA) of its single-dose COVID-19 vaccine to the Government of India.

What You Need to Know About the Johnson & Johnson Vaccine - COVID-19 - Johns Hopkins Bloomberg School of Public Health

The company stated that it was an important milestone to bring the single-dose Covid-19 vaccine to the people of India through collaboration with Biological E. Limited.

Biological E is going to be an important part of Johnson and Johnson's global supply chain network, the company stated. It has been helping to supply its Covid-19 vaccine Janssen via extensive collaborations and partnerships with governments.

-PTC News

 

  • Share